Corporación Acciona Energías Renovables, S.A. (BME:ANE)

Orchard Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	747	357	524	759	363	205.53
Depreciation & Amortization	630	536	472	420	376	347.62
Loss (Gain) on Sale of Assets	-571	-84	-133	-26	-1	0.36
Loss (Gain) on Equity Investments	-5	10	-81	-110	-63	-57.39
Asset Writedown	-134	-134	11	21	2	-84.5
Change in Inventory	-3	-10	6	-13	-16	5.61
Change in Other Net Operating Assets	44	157	-369	186	-24	-115.88
Other Operating Activities	-163	-164	-77	97	228	103.69
Operating Cash Flow	558	681	364	1,337	865	405.95
Operating Cash Flow Growth	28.28%	87.09%	-72.78%	54.57%	113.08%	-41.67%
Capital Expenditures	-1,393	-1,630	-1,907	-1,125	-721	-493.1
Sale of Property, Plant & Equipment	4	2	-	1	2	1.83
Cash Acquisitions	-331	-89	9	-148	-17	-11.11
Divestitures	1,242	266	-	31	29	0.21
Investing Cash Flow	-478	-1,451	-1,898	-1,241	-707	-502.18
Long-Term Debt Issued	-	1,275	4,176	2,385	1,652	422.43
Long-Term Debt Repaid	-	-792	-2,279	-2,389	-1,343	-151.35
Net Debt Issued (Repaid)	-173	483	1,897	-4	309	271.08
Common Dividends Paid	-143	-158	-230	-92	-261	-106.8
Other Financing Activities	162	197	-5	-18	-56	116.76
Financing Cash Flow	-154	522	1,662	-114	-8	281.03
Foreign Exchange Rate Adjustments	-20	7	-4	5	7	-13.08
Net Cash Flow	-94	-241	124	-13	157	171.72
Free Cash Flow	-835	-949	-1,543	212	144	-87.16
Free Cash Flow Growth	-	-	-	47.22%	-	-
Free Cash Flow Margin	-18.45%	-24.36%	-38.75%	4.52%	5.29%	-3.75%
Free Cash Flow Per Share	-2.57	-2.92	-4.72	0.64	0.44	-0.27
Cash Income Tax Paid	211	211	282	312	13	48.5
Levered Free Cash Flow	-625.75	-868.13	-1,314	467	-398.33	392.93
Unlevered Free Cash Flow	-513.88	-765	-1,233	523.25	-350.2	448.69
Change in Net Working Capital	379	26	322	-527	401.45	-346.2

Source: S&P Global Market Intelligence. Utility template. Financial Sources.